Aging and Heart Failure (eBook)
XXII, 475 Seiten
Springer New York (Verlag)
978-1-4939-0268-2 (ISBN)
This book synthesizes the major research advances in molecular, biochemical and translational aspects of aging and heart failure over the last four decades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of diastolic heart failure in the aging population; polypharmacy and adverse drug reactions in the aging population with heart failure; changes in the heart that accompany advancing age from humans to molecules; aging-associated alterations in myocardial inflammation and fibrosis and aging-related changes in mitochondrial function and implications for heart failure therapy. The book succinctly summarizes the large volume of data on these key topics and highlights novel pathways that need to be explored. Featuring contributions from leading clinician-scientists, Aging and Heart Failure: Mechanisms and Management is an authoritative resource on the major clinical issues in heart failure therapy in the elderly for cardiologists, gerontologists and internists.
Ch. 1: Changing demographics of the aging population with heart failure and implications for therapy Bodh I. JugduttCh. 2: Biology of aging and implications for heart failure therapy and prevention Bodh I. JugduttCh. 3: Hypertension and prevention of diastolic heart failure in the aging population Wilbert S. AronowMaciej BanachAli AhmedCh. 4: Aging and optimal therapy of systolic heart failure in the elderly Nakul Chander SharmaBodh I. Jugdutt Ch. 5: Atrial fibrillation and heart failure in the aging population Pedram KazemianBodh I. JugduttCh. 6: Optimizing therapy of heart failure in the aging population with monitoring in clinics John R. DimitryJustin A. EzekowitzCh. 7: Cardiac alterations in aging, hypertension and diastolic heart failure Edith PituskinD. Ian PatersonCh. 8: Polypharmacy and adverse drug reactions in the aging population with heart failure Michael W. RichWilliam J. NienaberCh. 9: Aging-related changes in vascular biology and implications for heart failure therapy in the aging population Michael Sean McMurtryCh. 10: Biomarkers and optimal management of heart failure in the aging population Hanna K. Gaggin James L. Januzzi, Jr.Ch. 11: Benefits of Exercise in the elderly Ezra A. AmsterdamC. Tissa KappagodaCh. 12: The RAAS in heart failure: an update on clinical trials and opportunities for therapy C. Tissa KappagodaEzra A. AmsterdamCh. 13: Aging and diastolic dysfunction – the interplay of inflammation and extracellular matrix regulation Peter Moritz BecherDirk Westermann,Carsten TschöpeCh. 14: Reperfusion and vasodilator therapy in elderly patients with STEMI and heart failure. Improving outcomesBodh I. Jugdutt, Anwar JelaniSeraj AbualnajaNakul Chander SharmaJoseph Szeman WongCh. 15: Erythropoietin therapy for heart failure Margarita BorovkaMathew S. MaurerCh. 16: Role of resistin in heart failure in the elderly Yasuchika TakeishiCh. 17: Role of coronary artery calcium in cardiovascular risk stratification and management in the aging population Craig R. ButlerPaolo RaggiCh. 18: Aging-and remodeling of the RAS and RAAS and related pathways. Implications for heart failure therapyBodh I. JugduttCh. 19: Aging and right ventricular failure from pulmonary hypertension: Effect of right ventricular and pulmonary artery remodelingJoseph Szeman WongBodh I. JugduttCh. 20: Biomarkers of cardiovascular aging Nirankar S. NekiParamjit S. TappiaNaranjan S. DhallaCh. 21: Changes in the heart that accompany advancing age: Humans to molecules Edward G. LakattaHarold A. SpurgeonAndzej M. JanczewskiCh. 22: Aging-related changes in cell death and cell survival pathways and implications for heart failure therapy Guido R.Y. De MeyerDorien M. SchrijversWim MartinetCh. 23: Aging-related changes in telomeres and telomerases and implications for heart failure therapy Pim van der HarstDirk J. van VeldhuisenCh. 24: Aging associated alterations in myocardial inflammation and fibrosis: pathophysiological perspectives and clinical implications Arti V. ShindeNikolaos G FrangogiannisCh. 25: Aging-related changes in extracellular matrix: implications for ventricular remodeling following myocardial infarction Nguyen T. NguyenAndriy YabluchanskiyLisandra E. de Castro BrásYu-Fang JinMerry L. LindseyCh. 26: Calcium handling defects and changes in cardiac function in the aging heart Adriana AdameovaNirankar S. NekiParamjit S. TappiaNaranjan S. DhallaCh. 27: Integrins: Implications for aging in heart failure therapy Laura L. DanielWilliam L. JoynerMahipal SinghKrishna SinghCh. 28: Adipokines as novel biomarkers in aging and heart failure Ken ShinmuraCh. 29: Aging-related changes in cellular and molecular mechanisms of post-infarction remodeling. Implications for heart failure therapy Henry Han-Jen ShihAndrew J. BoyleCh. 30: Aging-related changes in mitochondrial function and implication for heart failure therapy Satoaki MatobaAtsushi HoshinoHiroaki MatsubaraCh. 31: Regulation of SERCA via oxidative modifications: Implications for the pathophysiology of diastolic dysfunction in the aging heart Fuzhong QinRichard A. CohenWilson S. ColucciCh. 32: SMP-30 and aging-related cardiac remodeling and heart failure Satoshi SuzukiYasuchika Takeishi
Erscheint lt. Verlag | 19.2.2014 |
---|---|
Zusatzinfo | XXII, 475 p. 84 illus., 50 illus. in color. |
Verlagsort | New York |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Geriatrie |
Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie | |
Schlagworte | aging • Heart Failure • Myocardial Infarction • systolic heart failure |
ISBN-10 | 1-4939-0268-7 / 1493902687 |
ISBN-13 | 978-1-4939-0268-2 / 9781493902682 |
Haben Sie eine Frage zum Produkt? |
![PDF](/img/icon_pdf_big.jpg)
Größe: 15,0 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich